GlassScriptPhysician profile
Amy Yuan Li
NPI 1275823684
$2,440.45
in general payments reported to CMS, 2019-2025
22 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $117 · 2021: $188 · 2022: $234 · 2023: $465 · 2024: $304 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $907.80 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $256.44 | 2022-2025 | Prolaris |
| Procept Biorobotics Corporation | $240.99 | 2021-2025 | |
| Axonics, INC. | $170.66 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $140.48 | 2019-2025 | Moses 550 Dfl, Axonics |
| Progenics Pharmaceuticals, INC. | $116.83 | 2023-2025 | Pylarify |
| Laborie Medical Technologies Corp. | $94.12 | 2023-2024 | Endosheath Technology |
| Medtronic, INC. | $81.53 | 2022-2025 | Interstim |
| Teleflex LLC | $64.56 | 2022-2024 | Urolift |
| Tolmar Pharmaceuticals, INC. | $62.59 | 2020-2022 | |
| Antares Pharma, INC. | $50.00 | 2023 | Tlando, Xyosted |
| Astellas Pharma US INC | $39.68 | 2019 | |
| 180 Medical, INC. | $33.70 | 2024 | Gentlecath |
| Urogen Pharma, INC. | $30.79 | 2024 | |
| Urovant Sciences INC | $29.85 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $23.74 | 2024 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $23.27 | 2023 | Gemtesa |
| Janssen Biotech, INC. | $21.51 | 2019 | |
| Eisai INC. | $17.86 | 2025 | |
| Bk Medical Holding Company INC. | $15.60 | 2020 | |
| Merck Sharp & Dohme LLC | $14.63 | 2025 | Bridion |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.